-
Chloé de Balthasar
From the Department of Ophthalmology and Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, California;
-
Sweta Patel
From the Department of Ophthalmology and Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, California;
-
Arup Roy
Second Sight Medical Products, Inc., Sylmar, California; the
-
Ricardo Freda
From the Department of Ophthalmology and Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, California;
Doheny Eye Institute, Los Angeles, California; and the
-
Scott Greenwald
Second Sight Medical Products, Inc., Sylmar, California; the
-
Alan Horsager
From the Department of Ophthalmology and Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, California;
-
Manjunatha Mahadevappa
From the Department of Ophthalmology and Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, California;
Doheny Eye Institute, Los Angeles, California; and the
-
Douglas Yanai
From the Department of Ophthalmology and Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, California;
Doheny Eye Institute, Los Angeles, California; and the
-
Matthew J. McMahon
Second Sight Medical Products, Inc., Sylmar, California; the
-
Mark S. Humayun
From the Department of Ophthalmology and Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, California;
Doheny Eye Institute, Los Angeles, California; and the
-
Robert J. Greenberg
Second Sight Medical Products, Inc., Sylmar, California; the
-
James D. Weiland
From the Department of Ophthalmology and Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, California;
Doheny Eye Institute, Los Angeles, California; and the
-
Ione Fine
From the Department of Ophthalmology and Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, California;
Department of Psychology, University of Washington, Seattle, Washington.